MedPath

Fleet

Fleet Bisacodyl Enema NDC 0132-0703-36

Approved
Approval ID

324e61eb-8f6b-48d7-85c2-b1b5642691c9

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Jun 23, 2025

Manufacturers
FDA

C.B. Fleet Company, Inc.

DUNS: 003119054

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Bisacodyl

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0132-0703
Application NumberM007
Product Classification
M
Marketing Category
C200263
G
Generic Name
Bisacodyl
Product Specifications
Route of AdministrationRECTAL
Effective DateJune 23, 2025
FDA Product Classification

INGREDIENTS (8)

BISACODYLActive
Quantity: 10 mg in 30 mL
Code: 10X0709Y6I
Classification: ACTIB
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)Inactive
Code: HHT01ZNK31
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
OCTOXYNOL 9Inactive
Code: 7JPC6Y25QS
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 6/23/2025

PRINCIPAL DISPLAY PANEL

Fleet
Laxative
bisacodyl
Enema

![PRINCIPAL DISPLAY PANEL Fleet Laxative bisacodyl Enema ](/dailymed/image.cfm?name=fleet-bisacodyl-enema- ndc-0132-0703-36-02.jpg&id=882091)

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 6/23/2025

Uses

  • for relief of fecal impaction

  • for relief of occasional constipation

  • for removal of residue after barium administration

This product usually produces a bowel movement in 5 to 20 minutes.

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 6/23/2025

Purpose

Bisacodyl 10 mg .............Stimulant laxative/ bowel cleanser

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 6/23/2025

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 6/23/2025

Active ingredient (in each 30 mL delivered**dose)**

WARNINGS SECTION

LOINC: 34071-1Updated: 6/23/2025

Warnings

For rectal use only.

Do not use

when abdominal pain, nausea, or vomiting are present unless directed by a doctor.

Ask a doctor before using this product if you

  • have a sudden change in bowel habits lasting more than 2 weeks

  • already used a laxative for more than 1 week

This product may cause abdominal discomfort, faintness, rectal burning, and mild cramps.

Stop use and ask a doctor if you have

• rectal bleeding

• no bowel movement within 20 minutes of using this product.

These symptoms may indicate a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.****

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 6/23/2025

Directions

Single Daily Dosage (per 24 hours)

adults and children 12 years and over

1 bottle per day

children under 12 years

DO NOT USE

OTHER SAFETY INFORMATION

LOINC: 60561-8Updated: 6/23/2025

Other information

• store at temperatures not above 86˚ F (30˚ C)

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 6/23/2025

Inactive ingredients

carbomer 934P, glycerin, methylparaben, octoxynol-9, propylparaben, purified water, sodium hydroxide

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 6/23/2025

Questions?

or www.fleetlabs.com

**Tamper Evident:**bottle sealed for safety. If bottle wrapper with fleet emblem is torn, damaged or missing, do not use.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fleet - FDA Drug Approval Details